Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Urology|August 21, 2012
Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapyPaul L Nguyen, Ming-Hui Chen, Yuanye Zhang, et al.
Case Reports in Pancreatic Cancer|January 12, 2019
Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the LiteratureNoelle L Williams, Joshua D Palmer, Voichita Bar-Ad, et al.
Cancer|July 6, 2018
Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancerMartin T King, Paul L Nguyen, Ninjin Boldbaatar, et al.
Cancers|December 9, 2023
Evaluation of a Balloon Implant for Simultaneous Magnetic Nanoparticle Hyperthermia and High-Dose-Rate Brachytherapy of Brain Tumor Resection CavitiesShuying Wan, Dario B Rodrigues, Janet Kwiatkowski, et al.
Practical Radiation Oncology|March 29, 2014
Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiationAmar U Kishan, Ming-Hui Chen, Marian Loffredo, et al.
Urologic Oncology|March 4, 2008
Defining the rectal dose constraint for permanent radioactive seed implantation of the prostateMichele Albert, Jun S Song, Delray Schultz, et al.
Brachytherapy|March 29, 2020
A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancerRobert B Den, Jacob Greenspan, Laura A Doyle, et al.
American Journal of Clinical Oncology|February 28, 2015
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen TherapiesTu D Dan, Harriet B Eldredge-Hindy, Jean Hoffman-Censits, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.
Brachytherapy|January 15, 2019
Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapyMartin T King, Paul L Nguyen, Ninjin Boldbaatar, et al.
Pageof 10